Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
iShares MBS ETF
MBB
|
+$1.15B |
| 2 |
SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$746M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$682M |
| 4 |
Johnson & Johnson
JNJ
|
+$554M |
| 5 |
Microsoft
MSFT
|
+$487M |
Top Sells
| 1 |
LPT
Liberty Property Trust
LPT
|
+$139M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$75.9M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$48.7M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$39M |
| 5 |
Darden Restaurants
DRI
|
+$23.4M |
Sector Composition
| 1 | Technology | 18.66% |
| 2 | Healthcare | 13.41% |
| 3 | Financials | 11.59% |
| 4 | Industrials | 9.16% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2676
DELISTED
Cymabay Therapeutics
CBAY
| $556K | ﹤0.01% |
375,265
+5,561
| +2% | +$8.24K |
|
|
PCSB
2677
DELISTED
PCSB Financial Corporation
PCSB
| $551K | ﹤0.01% |
39,385
-2,705
| -6% | -$37.8K |
|
2678
Kiniksa Pharmaceuticals
KNSA
$2.68B
| $550K | ﹤0.01% |
35,496
+5,056
| +17% | +$78.3K |
|
2679
Pure Cycle
PCYO
$266M
| $549K | ﹤0.01% |
49,236
+4,549
| +10% | +$50.7K |
|
2680
Ocular Therapeutix
OCUL
$2.27B
| $548K | ﹤0.01% |
110,622
-4,133
| -4% | -$20.5K |
|
2681
Willdan Group
WLDN
$1.48B
| $546K | ﹤0.01% |
25,508
-134
| -0.5% | -$2.87K |
|
2682
Geospace Technologies
GEOS
$211M
| $544K | ﹤0.01% |
84,994
+1,528
| +2% | +$9.78K |
|
2683
Scholar Rock
SRRK
$3B
| $543K | ﹤0.01% |
44,777
+191
| +0.4% | +$2.32K |
|
|
ACRE
2684
Ares Commercial Real Estate
ACRE
$267M
| $542K | ﹤0.01% |
77,420
+9,706
| +14% | +$68K |
|
2685
Civista Bancshares
CIVB
$407M
| $541K | ﹤0.01% |
36,108
-957
| -3% | -$14.3K |
|
|
TLRD
2686
DELISTED
Tailored Brands, Inc.
TLRD
| $538K | ﹤0.01% |
309,119
-139,636
| -31% | -$243K |
|
|
ALBO
2687
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $537K | ﹤0.01% |
32,753
+4,221
| +15% | +$69.2K |
|
2688
RGC Resources
RGCO
$227M
| $536K | ﹤0.01% |
18,498
+138
| +0.8% | +$4K |
|
2689
SoundThinking
SSTI
$160M
| $535K | ﹤0.01% |
19,463
+258
| +1% | +$7.09K |
|
|
AFMD
2690
DELISTED
Affimed
AFMD
| $533K | ﹤0.01% |
33,727
| – | – |
|
|
HARP
2691
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $530K | ﹤0.01% |
4,574
+58
| +1% | +$6.72K |
|
|
PROS
2692
DELISTED
ProSight Global, Inc.
PROS
| $530K | ﹤0.01% |
54,322
+715
| +1% | +$6.98K |
|
|
ACR
2693
ACRES Commercial Realty
ACR
$156M
| $529K | ﹤0.01% |
63,837
+397
| +0.6% | +$3.29K |
|
|
ONDK
2694
DELISTED
On Deck Capital, Inc.
ONDK
| $529K | ﹤0.01% |
342,872
-197,308
| -37% | -$304K |
|
2695
Comstock Resources
CRK
$4.65B
| $528K | ﹤0.01% |
97,829
+2,202
| +2% | +$11.9K |
|
|
GPX
2696
DELISTED
GP Strategies Corp.
GPX
| $527K | ﹤0.01% |
80,865
-590
| -0.7% | -$3.85K |
|
2697
RBB Bancorp
RBB
$333M
| $525K | ﹤0.01% |
38,215
+108
| +0.3% | +$1.48K |
|
2698
Vishay Precision Group
VPG
$396M
| $524K | ﹤0.01% |
26,088
-124
| -0.5% | -$2.49K |
|
|
CDR
2699
DELISTED
Cedar Realty Trust, Inc
CDR
| $522K | ﹤0.01% |
84,679
-49,831
| -37% | -$307K |
|
2700
Lexicon Pharmaceuticals
LXRX
$392M
| $521K | ﹤0.01% |
266,693
+3,843
| +1% | +$7.51K |
|